Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
300.2 USD | -1.85% | -4.56% | +4.23% |
05-28 | US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment | RE |
05-28 | Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.23% | 164B | |
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
-1.70% | 164B | |
-1.31% | 122B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Amgen Reaches Settlement With FTC to Move Ahead With Horizon Acquisition